Work

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Year: 2013

Type: article

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-013-2886-9

Authors: Matthew H. G. Katz, Robert Marsh, Joseph M. Herman, Qian Shi, Eric Collison, Alan P. Venook, Hedy L. Kindler, Steven R. Alberts, Philip Philip, Andrew M. Lowy, Peter W. T. Pisters, Mitchell C. Posner, Jordan D. Berlin, Syed A. Ahmad

Institutions: The University of Texas MD Anderson Cancer Center, University of Chicago, Johns Hopkins University, Mayo Clinic, University of California, San Francisco, The Barbara Ann Karmanos Cancer Institute, University of California San Diego, Vanderbilt University, University of Cincinnati, University of Cincinnati Medical Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G111615301, Cancer Center Support Grant

OpenAlex ID: W2030126221

FWCI: 16.59

Cites: 47

Cited by: 340

Related to: 10